not too bad. if I read it right, 0.04 cents per share for Q4 vs. -0.07 loss expected. Non-gaap of course. Don't think we rise or drop too much but I'll take a rise. wait and see for clinical trials in 2013. so far, no AH's action.
yeah, news headlines are negative. I thought sales were up from last Q but I have to reread the reports. No bid/ask yet. No downgrades or nothing that I can find. Somehow, they will push this down is my guess. I don't think there were many AH trades (I saw 3K at one point max). Wish JNJ or GSK or ?? would just step up and take a chance at VRTX at say $65 and run the rest of the trials themselves. I know, not going to happen. I think the chance of 42 is greater than 49 at this point. Time will tell
been waiting a long time for them. so frustrated and you can see it in my posts. I'm long in the low to mid 50's. Been in and out of it in the low 40's. report was good. profit vs. loss. revenues up from expectations. AH's is just about dead. We'll see after the CC and tomorrow's action. Everyone says it - one good trial and this is over 60 in a blink of the eye. We have to wait for it.
Go ahead and post your opinions on vrtx. I'd love to hear them. so would others. Good night. No action and it won't get to my prices so I'm going to drink.